Tag: FDA fast track

In 2025, the landscape of pain management is rapidly evolving. While traditional opioid-based treatments continue to face scrutiny due to addiction risks, the rise of non-opioid pain drugs offers promising alternatives for chronic pain sufferers. However, alongside these medical advances, off-label use of ivermectin for pain relief has surfaced as a controversial and dangerous trend. […]